Clinical Trials Browser

Phase 1 × Has results × peposertib × Clear all

NCT03724890 2025-04-10

Study of Avelumab-M3814 Combinations

Phase 1 Completed

57 enrolled 56 charts

Neoplasms

NCT02516813 2024-10-15

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Phase 1 Completed

52 enrolled 43 charts

Other solid neoplasm

Advanced Solid Tumors